Abrdn Life Sciences Investors (HQL) Competitors $11.80 +0.14 (+1.21%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$11.82 +0.02 (+0.16%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HQL vs. CET, GSBD, MFIC, NMFC, MUC, BCSF, BBDC, AWF, PFLT, and HQHShould you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include Central Securities (CET), Goldman Sachs BDC (GSBD), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), BlackRock MuniHoldings California Quality Fund (MUC), Bain Capital Specialty Finance (BCSF), Barings BDC (BBDC), AllianceBernstein Global High Income Fund (AWF), PennantPark Floating Rate Capital (PFLT), and Abrdn Healthcare Investors (HQH). These companies are all part of the "financial services" industry. Abrdn Life Sciences Investors vs. Central Securities Goldman Sachs BDC MidCap Financial Investment New Mountain Finance BlackRock MuniHoldings California Quality Fund Bain Capital Specialty Finance Barings BDC AllianceBernstein Global High Income Fund PennantPark Floating Rate Capital Abrdn Healthcare Investors Central Securities (NYSE:CET) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, community ranking, valuation, risk, dividends, media sentiment and earnings. Is CET or HQL more profitable? Company Net Margins Return on Equity Return on Assets Central SecuritiesN/A N/A N/A Abrdn Life Sciences Investors N/A N/A N/A Does the MarketBeat Community prefer CET or HQL? Abrdn Life Sciences Investors received 95 more outperform votes than Central Securities when rated by MarketBeat users. CompanyUnderperformOutperformCentral SecuritiesN/AN/AAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% Which has stronger valuation & earnings, CET or HQL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentral Securities$296.20M4.15N/AN/AN/AAbrdn Life Sciences Investors$86.69M3.93N/AN/AN/A Which has more volatility & risk, CET or HQL? Central Securities has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Is CET or HQL a better dividend stock? Central Securities pays an annual dividend of $2.25 per share and has a dividend yield of 5.3%. Abrdn Life Sciences Investors pays an annual dividend of $1.47 per share and has a dividend yield of 12.5%. Does the media refer more to CET or HQL? In the previous week, Abrdn Life Sciences Investors had 8 more articles in the media than Central Securities. MarketBeat recorded 9 mentions for Abrdn Life Sciences Investors and 1 mentions for Central Securities. Central Securities' average media sentiment score of 1.81 beat Abrdn Life Sciences Investors' score of 0.63 indicating that Central Securities is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Central Securities 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Abrdn Life Sciences Investors 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of CET or HQL? 8.7% of Central Securities shares are owned by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. 9.5% of Central Securities shares are owned by company insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAbrdn Life Sciences Investors beats Central Securities on 5 of the 9 factors compared between the two stocks. Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricAbrdn Life Sciences InvestorsInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$340.72M$7.45B$10.85B$18.41BDividend Yield16.50%7.07%5.79%4.19%P/E RatioN/A3.5321.5331.09Price / Sales3.9324.1925.4526.55Price / CashN/A7.5117.6217.53Price / BookN/A0.872.564.30Net IncomeN/A$66.51M$1.03B$1.02B1 Month Performance-9.44%-5.12%-4.09%-8.21%1 Year Performance-7.77%0.38%531.55%1.69% Abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLAbrdn Life Sciences InvestorsN/A$11.80+1.2%N/A-7.8%$340.72M$86.69M0.00N/AInsider TradeShort Interest ↑News CoverageCETCentral SecuritiesN/A$43.39+1.1%N/A+5.6%$1.26B$296.20M0.006News CoverageGSBDGoldman Sachs BDC2.4515 of 5 stars$10.21+1.0%$13.00+27.3%-30.7%$1.20B$78.71M14.59N/AShort Interest ↑Positive NewsMFICMidCap Financial Investment3.3237 of 5 stars$11.16+0.9%$14.50+29.9%-21.7%$1.05B$110.35M7.15N/ANews CoverageNMFCNew Mountain Finance3.4584 of 5 stars$9.34+1.1%$11.00+17.8%-21.8%$1.01B$123.78M8.90N/APositive NewsHigh Trading VolumeMUCBlackRock MuniHoldings California Quality FundN/A$10.37+1.2%N/A-3.8%$995.97M$6.39M0.00147,000Ex-DividendShort Interest ↓News CoveragePositive NewsBCSFBain Capital Specialty Finance2.7361 of 5 stars$14.58+2.5%$18.00+23.5%-4.6%$942.09M$138.19M7.331,000Short Interest ↓BBDCBarings BDC2.1453 of 5 stars$8.44+0.8%$9.50+12.6%-6.2%$889.65M$123.59M8.1226News CoverageAWFAllianceBernstein Global High Income FundN/A$10.07+0.7%N/A+0.9%$868.34M$152.17M0.00N/APFLTPennantPark Floating Rate Capital2.0401 of 5 stars$9.66+1.5%$11.67+20.8%-13.4%$849.66M$114.06M6.90658Ex-DividendAnalyst ForecastHQHAbrdn Healthcare InvestorsN/A$15.12+1.6%N/A-4.5%$765.45M$186.46M0.00147,000Short Interest ↓Positive News Related Companies and Tools Related Companies CET Competitors GSBD Competitors MFIC Competitors NMFC Competitors MUC Competitors BCSF Competitors BBDC Competitors AWF Competitors PFLT Competitors HQH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HQL) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HQL Stock Free HQL Stock Alerts